Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
about
A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzymeThe Dipeptidyl Peptidase Family, Prolyl Oligopeptidase, and Prolyl Carboxypeptidase in the Immune System and Inflammatory Disease, Including AtherosclerosisThe expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patientsMacrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.A snapshot of the Ixodes scapularis degradomeNontraditional roles of angiotensin-converting enzyme.The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors.Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumorsTargeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironmentsThe anti-inflammatory peptide Ac-SDKP is released from thymosin-β4 by renal meprin-α and prolyl oligopeptidase.OsPOP5, a prolyl oligopeptidase family gene from rice confers abiotic stress tolerance in Escherichia coliThymosin β4 and its degradation product, Ac-SDKP, are novel reparative factors in renal fibrosis.Prolyl endopeptidase activity is correlated with colorectal cancer prognosis.Antifibrotic peptide N-acetyl-Ser-Asp-Lys-Pro (Ac-SDKP): opportunities for angiotensin-converting enzyme inhibitor design.Angiotensin-converting enzyme and the tumor microenvironment: mechanisms beyond angiogenesis.Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.Suppression of tumor growth in mice by rationally designed pseudopeptide inhibitors of fibroblast activation protein and prolyl oligopeptidase.A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.Mechanism of Action of Prolyl Oligopeptidase (PREP) in Degenerative Brain Diseases: Has Peptidase Activity Only a Modulatory Role on the Interactions of PREP with Proteins?Mechanisms in hypertension and target organ damage: Is the role of the thymus key? (Review).
P2860
Q24306614-5DEE8471-8B8E-4839-94C9-D287C38EED25Q26795473-51D9AC9B-F4A1-4724-8AF4-91840012D16DQ28607060-1E6AF692-CC6F-4742-91AA-39CB7D6D9544Q30278005-800464BE-C6A9-4F69-96FD-A1C0D5F6EE05Q35085725-C3D136B5-6EE3-47AB-9BEA-3B88C31F9468Q35836666-A9C61FCC-A2F9-450E-AEBB-968606C06E37Q36356011-E45DE48F-92D1-4DF8-9B20-C2ACDF70CE5FQ36473292-36B4D512-DFB3-4A45-A0F3-95DACD54F3E2Q36730567-FB7EB98E-AC7B-432B-B689-BB0430C839E2Q36957095-E64060C3-0D16-469E-A738-8E0EE642E6C5Q37291261-334F1CD4-2BA1-4E96-9072-570278A68C78Q37315924-58F91591-D353-4648-A21B-D03185AC7AFAQ37488703-89C5EF07-E8CC-4F6A-AC39-CCA30665A52CQ38076770-47B6A7D8-8FFE-46F7-9771-7754A2FD4C5AQ38112273-B37E3FD4-3676-4A43-94C5-889A39E953A4Q38668992-793116CE-5D2E-4927-856B-E08469EC0CC1Q38916346-FBD9CC4D-C1C1-40C2-8CDA-F8DDF5C61BDFQ39414467-F4EC69F9-8E28-42B9-B361-16BD7589A8E2Q42028017-39041425-E8AA-4D7A-8209-BB7DDBC4CCD8Q55032413-5F25EECF-3392-4685-8E62-7F0655AEBAD7
P2860
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prolyl oligopeptidase induces ...... in a novel regulatory manner.
@ast
Prolyl oligopeptidase induces ...... in a novel regulatory manner.
@en
type
label
Prolyl oligopeptidase induces ...... in a novel regulatory manner.
@ast
Prolyl oligopeptidase induces ...... in a novel regulatory manner.
@en
prefLabel
Prolyl oligopeptidase induces ...... in a novel regulatory manner.
@ast
Prolyl oligopeptidase induces ...... in a novel regulatory manner.
@en
P2093
P2860
P50
P1476
Prolyl oligopeptidase induces ...... o in a novel regulatory manner
@en
P2093
J Tenorio-Laranga
M J Moreno-Baylach
R Vázquez-Sánchez
P2860
P304
P356
10.1111/J.1476-5381.2010.01146.X
P407
P577
2011-08-01T00:00:00Z